Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Depreciation & Amortization (CF) (2019 - 2021)

Historic Depreciation & Amortization (CF) for Black Diamond Therapeutics (BDTX) over the last 3 years, with Q4 2021 value amounting to $123000.0.

  • Black Diamond Therapeutics' Depreciation & Amortization (CF) rose 72000.0% to $123000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $205000.0, marking a year-over-year increase of 29423.08%. This contributed to the annual value of $343000.0 for FY2024, which is 2151.03% down from last year.
  • As of Q4 2021, Black Diamond Therapeutics' Depreciation & Amortization (CF) stood at $123000.0, which was up 72000.0% from $43000.0 recorded in Q3 2021.
  • In the past 5 years, Black Diamond Therapeutics' Depreciation & Amortization (CF) registered a high of $123000.0 during Q4 2021, and its lowest value of $9000.0 during Q4 2019.
  • Moreover, its 3-year median value for Depreciation & Amortization (CF) was $13500.0 (2019), whereas its average is $25333.3.
  • In the last 5 years, Black Diamond Therapeutics' Depreciation & Amortization (CF) crashed by 1666.67% in 2020 and then skyrocketed by 72000.0% in 2021.
  • Quarter analysis of 3 years shows Black Diamond Therapeutics' Depreciation & Amortization (CF) stood at $9000.0 in 2019, then soared by 66.67% to $15000.0 in 2020, then soared by 720.0% to $123000.0 in 2021.
  • Its Depreciation & Amortization (CF) stands at $123000.0 for Q4 2021, versus $43000.0 for Q3 2021 and $20000.0 for Q2 2021.